Join
Live feed
·
PRReleasevia Quantisnow
Biophytis SA logo

Biophytis Obtains IND Approval from the FDA to Start its Phase 2 OBA Study in Obesity

ByQuantisnow·Wall Street's wire, on your screen.
BPTS· Biophytis SA
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BPTS (Biophytis SA) and more on Quantisnow.